ANGPT1 and non-small cell lung carcinoma: In contrast, Park et al. [23] first revealed that patients diagnosed with NSCLC exhibit lower serum concentrations of Ang-1 compared to the control group, while patients with higher levels of Ang-1 have better disease and relapse-free survival.